You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DESMOPRESSIN ACETATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Desmopressin Acetate, and what generic alternatives are available?

Desmopressin Acetate is a drug marketed by Am Regent, Bedford, Dr Reddys, Gland, Gland Pharma Ltd, Hospira, Meitheal, Sagent Pharms Inc, Sun Pharm Inds Ltd, UBI, Sun Pharm Inds, Bausch, Abhai Llc, Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma, Ferring, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Natco Pharma Usa, Novast Labs, Apotex, Sun Pharm, and Zydus Pharms. and is included in twenty-eight NDAs.

The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desmopressin Acetate

A generic version of DESMOPRESSIN ACETATE was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESMOPRESSIN ACETATE?
  • What are the global sales for DESMOPRESSIN ACETATE?
  • What is Average Wholesale Price for DESMOPRESSIN ACETATE?
Drug patent expirations by year for DESMOPRESSIN ACETATE
Drug Prices for DESMOPRESSIN ACETATE

See drug prices for DESMOPRESSIN ACETATE

Recent Clinical Trials for DESMOPRESSIN ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityN/A
Indiana Hemophilia &Thrombosis Center, Inc.Phase 4
Genentech, Inc.Phase 4

See all DESMOPRESSIN ACETATE clinical trials

US Patents and Regulatory Information for DESMOPRESSIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Usa DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 200653-002 Jun 27, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharma DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 207880-002 May 26, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novast Labs DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 208357-001 Jun 6, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 077122-001 Jan 25, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent DESMOPRESSIN ACETATE desmopressin acetate INJECTABLE;INJECTION 091374-001 Feb 14, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 076470-002 Jul 1, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ferring DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 021795-002 May 8, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DESMOPRESSIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 021795-001 May 8, 2008 ⤷  Sign Up ⤷  Sign Up
Ferring DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 021795-002 May 8, 2008 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DESMOPRESSIN ACETATE

See the table below for patents covering DESMOPRESSIN ACETATE around the world.

Country Patent Number Title Estimated Expiration
Hong Kong 1072009 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof. ⤷  Sign Up
South Africa 200600018 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof ⤷  Sign Up
New Zealand 544104 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof ⤷  Sign Up
Russian Federation 2005141230 ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЕСМОПРЕССИНА В ВИДЕ ТВЕРДОЙ ДОЗИРОВАННОЙ ЛЕКАРСТВЕННОЙ ФОРМЫ И СПОСОБ ЕЕ ИЗГОТОВЛЕНИЯ ⤷  Sign Up
Taiwan 200509995 Pharmaceutical composition as solid dosage form and method for manufacturing thereof ⤷  Sign Up
Slovenia 1500390 ⤷  Sign Up
Taiwan I268782 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for DESMOPRESSIN ACETATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2712622 LUC00015 Luxembourg ⤷  Sign Up PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
2712622 C02712622/01 Switzerland ⤷  Sign Up PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018
3225249 300983 Netherlands ⤷  Sign Up PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513
2712622 122017000006 Germany ⤷  Sign Up PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
3225249 2019C/520 Belgium ⤷  Sign Up PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513
3225249 CA 2019 00023 Denmark ⤷  Sign Up PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.